Difficulty: Medium
Average Score: 87%
Practice
Fluorouracil belongs to:
Correct answer
B
Rationale
In the context of pharmacological treatments, it is crucial for learners to understand the classification of drugs and their mechanisms of action. Fluorouracil, a widely used chemotherapy drug, belongs to the category of antimetabolites. Antimetabolites are a class of drugs that interfere with the normal metabolic processes of cells by mimicking natural substances within the cell. Fluorouracil specifically disrupts DNA and RNA synthesis in rapidly dividing cancer cells.
Option A, antibiotics, are drugs used to treat bacterial infections by targeting bacterial cell structures or processes, not cancer cells. Option C, plant alkaloids, are derived from plants and are commonly used in cancer treatment, but they work through a different mechanism than antimetabolites. Option D, bone marrow growth factor, is a substance that stimulates the production of blood cells and is not related to the mechanism of action of antimetabolites like fluorouracil.
Educationally, understanding the classification of drugs like fluorouracil is essential for healthcare professionals to make informed decisions about treatment options for patients across the lifespan. This knowledge enables practitioners to select the most appropriate medications based on their mechanism of action and potential side effects, ultimately improving patient outcomes.
Option A, antibiotics, are drugs used to treat bacterial infections by targeting bacterial cell structures or processes, not cancer cells. Option C, plant alkaloids, are derived from plants and are commonly used in cancer treatment, but they work through a different mechanism than antimetabolites. Option D, bone marrow growth factor, is a substance that stimulates the production of blood cells and is not related to the mechanism of action of antimetabolites like fluorouracil.
Educationally, understanding the classification of drugs like fluorouracil is essential for healthcare professionals to make informed decisions about treatment options for patients across the lifespan. This knowledge enables practitioners to select the most appropriate medications based on their mechanism of action and potential side effects, ultimately improving patient outcomes.